Everolimus-associated focal segmental glomerulosclerosis in a liver transplant recipient

Nephrology (Carlton). 2021 Apr;26(4):371-372. doi: 10.1111/nep.13812. Epub 2020 Dec 9.

Authors

Shun Manabe¹, Ayami Ino¹, Yoei Miyabe¹, Sekiko Taneda², Hiroshi Kataoka^{1

3}, Toshio Mochizuki^{1

3}, Kosaku Nitta¹

Affiliations

¹ Department of Nephrology, Tokyo Women's Medical University, Tokyo, Japan.
² Department of Pathology, Tokyo Women's Medical University, Tokyo, Japan.
³ Clinical Research Division for Polycystic Kidney Disease, Department of Nephrology, Tokyo Women's Medical University, Tokyo, Japan.

PMID: 33300227
DOI: 10.1111/nep.13812

No abstract available

Publication types

Case Reports
Letter

MeSH terms

Everolimus / adverse effects*
Glomerulosclerosis, Focal Segmental / chemically induced*
Humans
Liver Transplantation*
Male
Middle Aged
Postoperative Complications / chemically induced*

Substances

Everolimus